| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 2 917-924, Copyright © 1995 by American Association of Immunologists
ARTICLES |
N Chirmule, TW McCloskey, R Hu, VS Kalyanaraman and S Pahwa
Department of Pediatrics, North Shore University Hospital-Cornell University Medical College, Manhasset, NY 11030, USA.
One mechanism of the immune suppression in HIV infection has been postulated as being caused by the interaction of HIV envelope glycoprotein gp120 with CD4 molecules. Thus, pretreatment of purified peripheral blood T cells or CD4+ T cell clones with gp120 (or an anti- CD4 mAb) results in inhibition of anti-CD3 mAb-induced proliferative responses. In this study, we have analyzed the role of the interacting pairs of costimulatory molecules, CD28-B71 (CD80) and CD40 ligand (CD40L)-CD40, to elucidate further the mechanism of HIV gp120-induced inhibitory effects on T cell functions. Interactions between CD28-B71 and CD40L-CD40 were found to be essential for the anti-CD3 mAb-induced T cell proliferation, as demonstrated by up-regulation of B71 and CD40L and the ability of anti-B71 and anti-CD40L mAbs to inhibit this response. Pretreatment of CD4+ T cells with gp120 before CD3 ligation with anti-CD3 mAb resulted in failure of up-regulation of CD40L on T cells and B71 on APC. Exogenous addition of anti-CD28 mAb overcame the inhibitory effect of gp120 on anti-CD3 mAb-induced T cell proliferation. We conclude that binding of gp120 to CD4 molecules on T cells may interrupt the sequential cascade of intercellular interaction involving 1) Ag/MHC class II-TCR/CD4, 2) CD40L-CD40, and 3) B71-CD28. These studies indicate that the CD4-gp120 interaction results in dysregulation of expression of costimulatory molecules, CD40L, and B71 expression on T cells and APC, respectively, thereby contributing to the T cell hyporesponsiveness in HIV infection.
This article has been cited by other articles:
|
|
 |
|
  R. Zhang, J. D. Lifson, and C. Chougnet Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions Blood, March 1, 2006; 107(5): 1989 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard HIV Type 1 Glycoprotein 120 Inhibits Human B Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 12, CC Chemokine Ligand (CCL)20, and CCL21 J. Immunol., July 1, 2005; 175(1): 302 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Hodara, M. C. Velasquillo, L. M. Parodi, and L. D. Giavedoni Expression of CD154 by a Simian Immunodeficiency Virus Vector Induces Only Transitory Changes in Rhesus Macaques J. Virol., April 15, 2005; 79(8): 4679 - 4690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. V. Sipsas and P. P. Sfikakis Expanding Role of Circulating Adhesion Molecules in Assessing Prognosis and Treatment Response in Human Immunodeficiency Virus Infection Clin. Vaccine Immunol., November 1, 2004; 11(6): 996 - 1001. [Full Text] [PDF]
|
|
|
|
|
|
A. Smed-Sorensen, K. Lore, L. Walther-Jallow, J. Andersson, and A.-L. Spetz HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation Blood, November 1, 2004; 104(9): 2810 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Borkow and Z. Bentwich Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhang, C. J. Fichtenbaum, D. A. Hildeman, J. D. Lifson, and C. Chougnet CD40 Ligand Dysregulation in HIV Infection: HIV Glycoprotein 120 Inhibits Signaling Cascades Upstream of CD40 Ligand Transcription J. Immunol., February 15, 2004; 172(4): 2678 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chougnet Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells J. Leukoc. Biol., November 1, 2003; 74(5): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Villinger, G. T. Brice, A. E. Mayne, P. Bostik, K. Mori, C. H. June, and A. A. Ansari Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4+ cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status Blood, January 15, 2002; 99(2): 590 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Kornbluth The emerging role of CD40 ligand in HIV infection J. Leukoc. Biol., September 1, 2000; 68(3): 373 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ma and L. J. Montaner Proinflammatory response and IL-12 expression in HIV-1 infection J. Leukoc. Biol., September 1, 2000; 68(3): 383 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Moir, R. Lapointe, A. Malaspina, M. Ostrowski, C. E. Cole, T.-W. Chun, J. Adelsberger, M. Baseler, P. Hwu, and A. S. Fauci CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir J. Virol., October 1, 1999; 73(10): 7972 - 7980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Subauste, M. Wessendarp, R. U. Sorensen, and L. E. Leiva CD40-CD40 Ligand Interaction Is Central to Cell-Mediated Immunity Against Toxoplasma gondii: Patients with Hyper IgM Syndrome Have a Defective Type 1 Immune Response That Can Be Restored by Soluble CD40 Ligand Trimer J. Immunol., June 1, 1999; 162(11): 6690 - 6700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, S. A. Furman, C. R. Bradford, and A. E. Chang Expanded Tumor-reactive CD4+ T-Cell Responses to Human Cancers Induced by Secondary Anti-CD3/Anti-CD28 Activation Clin. Cancer Res., February 1, 1999; 5(2): 461 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bonnard, L. Haughn, and M. Julius CD4-Mediated Inhibiton of IL-2 Production in Activated T Cells J. Immunol., February 1, 1999; 162(3): 1252 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kornbluth, K. Kee, and D. D. Richman CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta -chemokines PNAS, April 28, 1998; 95(9): 5205 - 5210. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
